Fundamental Analysis (FA)
Framework: DCF Benchmarked
Join Palmy To Bypass The Blur →
For PSEC
Valuation Weak
28%
Profitability n.A.
Fin. Growth Positive
67%
Leverage & Liquidity Weak
17%
Per Share Metrics Bad
0%
Fin. Health n.A.
Fundamental Analysis (FA)
Benchmarked
1 Financial Health
Metric Q2 Q3 Δ in %
Current Ratio 14.27 0.72 0.63
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA -93.15 13.19 192.40
Naive Interpretation member
2 Per Share
Metric Q2 Q3 Δ in %
Book Value 42.71 12.79 8.96
Cash -45.50 0.13 0.24
Capex 0.00 0.00 0.00
Free Cash Flow -17.64 0.16 0.19
Revenue -37.78 0.32 0.51
Naive Interpretation member
3 Profitability
Metric Q2 Q3 Δ in %
Gross Margin -21.34 0.57 0.73
Operating Margin 2277.06 1.39 0.06
ROA 412.13 0.02 < 0.005
ROE 261.51 0.03 < 0.005
ROIC -85.97 < 0.005 0.01
Naive Interpretation member
4 Valuation
The "Valuation Entry" for the Focus of PSEC is permitted for members.
5 Growth
The "Growth Entry" for the Focus of PSEC is permitted for members.
6 Leverage & Liquidity
The "Leverage & Liquidity Entry" for the Focus of PSEC is permitted for members.